

AirSculpt stock rebounds after steep drop as delayed filing, weak revenue, and 2026 outlook raise investor questions and cautious optimism.
You can purchase shares of AirSculpt Technologies (NASDAQ:AIRS) through any online brokerage.
Other companies in AirSculpt Technologies’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Quest Diagnostics Inc (NYSE:DGX), Labcorp Holdings Inc (NYSE:LH) and Guardant Health Inc (NASDAQ:GH).
AirSculpt Technologies has a consensus price target of $4.50.
The stock price for AirSculpt Technologies (NASDAQ: AIRS) is $1.25 last updated October 23, 2026 at 8:50 AM EDT.
There are no upcoming dividends for AirSculpt Technologies.
AirSculpt Technologies does not have any upcoming earnings scheduled.
There is no upcoming split for AirSculpt Technologies.
AirSculpt Technologies is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting...